Infants with Congenital Heart Disease drug treatment

Congenital heart disease is noted on his existing heart disease, that is, in the mother during pregnancy due to abnormal development of cardiovascular malformations caused by heart disease, congenital heart disease in children is the most common cardiovascular diseases in a class of heart disease, the incidence of live births to about the 7% to 8% that is about Health 11 have one. General congenital heart disease at three categories. (1) left → right shunt: (non-cyanotic), VSD, the lack of patent ductus arteriosus is the most common clinical manifestation of recurrent colds, fever, pneumonia, sweating, suffering from weight loss, weight is not long. (2) the right → left shunt: (also called cyanotic), tetralogy of Fallot, the most common vascular dislocation. Clinical manifestations of birth or birth six months after your lips, face, easy sweat, breathe, but not cold, began to walk after Hi SJS Institute, which goes a squat about. (3) No shunt to pulmonary stenosis, coarctation of the aorta common, common clinical boy, not more than a cold, looked like a normal, long to 7 ~ 8-year-old walking sooner or later there when rehoused or your lips such as asthma phenomenon. Children found more than performance, we must consider whether the children have congenital heart disease, and promptly to the relevant hospitals to check. Traditional methods of treatment of congenital heart disease for radical surgery, with the development of science and technology in recent years has undertaken a number of new approaches, we focus here on the medication. Medication simple, convenient, no side effects, can relieve the plight stroke, and cost savings. In foreign countries, on congenital heart disease in infants is the first drug treatment, drug treatment found to be ineffective, further surgical treatment. So what kind of congenital heart disease can be carried out medication? (1) → simple left-right shunt: Room is missing, the missing, such as patent ductus arteriosus. (2) within the age 3-year-old children with the best effect, the age of children grow up effectively. (3) without complications. (4) defect mouth SMEs, large gaps can be closed, but rare. Most see gap narrowed after treatment. We went through many years of clinical treatment, found that the drug after treatment, and the shortfall closure rate was as high as 74.3 percent, far more natural closure (without drug treatment shut 14% ~ 30%) is higher.